SCHEMBL18519552

SCHEMBL18519552

CC(C)(C)OC(=O)NC1(CN(C(=O)OC(C)(C)C)c2ccc([N+](=O)[O-])cn2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.41
PKM P14618 1/20 0.38
GAA P10253 2/20 0.38
CYP1A2 P05177 2/20 0.38
MAPT P10636 6/20 0.38
RAB9A P51151 5/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
NPC1 O15118 4/20 0.38
LMNA P02545 3/20 0.38
ALDH1A1 P00352 2/20 0.38
POLB P06746 1/20 0.37
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35
MMP8 P22894 1/20 0.35
MMP13 P45452 1/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
HTT P42858 1/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18519553 0.83 MAPKAPK2 (0.33)
SCHEMBL26640360 0.80 PKM (0.46) CYP2C19PKMGAACYP1A2MAPT
SCHEMBL18519763 0.79 CYP2C19 (0.44) CYP2C19GAACYP1A2MAPTRAB9A
SCHEMBL18519550 0.79 MAPT (0.50) CYP2C19GAACYP1A2MAPTRAB9A
SCHEMBL477465 0.77 CYP2C19 (0.50) CYP2C19PKMGAACYP1A2MAPT
SCHEMBL6019396 0.75 CYP2C19 (0.51) CYP2C19PKMGAACYP1A2MAPT
SCHEMBL7913868 0.73 CYP2C19 (0.49) CYP2C19PKMGAACYP1A2MAPT
SCHEMBL6498913 0.73 MAPT (0.39) CYP2C19PKMMAPTRAB9ALMNA
SCHEMBL26626463 0.72 CYP2C19 (0.47) CYP2C19PKMGAACYP1A2MAPT
SCHEMBL115820 0.71 CYP1A2 (0.65) CYP2C19GAACYP1A2MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017024996-A1 HYDROXY AMIDINE DERIVATIVE, PREPARATION METHOD AND USE IN MEDICINE THEREOF 江苏恒瑞医药股份有限公司 2017-02-16 WO disclosed